Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021

SELL
$50.47 - $66.26 $580,808 - $762,520
-11,508 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$51.97 - $63.0 $598,070 - $725,004
11,508 New
11,508 $691,000
Q1 2020

May 15, 2020

SELL
$28.4 - $50.7 $2.31 Million - $4.12 Million
-81,352 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$36.31 - $46.83 $2.95 Million - $3.81 Million
81,352 New
81,352 $3.69 Million
Q3 2019

Nov 14, 2019

SELL
$35.66 - $44.99 $1.56 Million - $1.97 Million
-43,840 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$36.57 - $47.97 $1.6 Million - $2.1 Million
43,840 New
43,840 $1.91 Million

Others Institutions Holding PCRX

About Pacira BioSciences, Inc.


  • Ticker PCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,824,200
  • Market Cap $892M
  • Description
  • Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...
More about PCRX
Track This Portfolio

Track Quantitative Investment Management, LLC Portfolio

Follow Quantitative Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantitative Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quantitative Investment Management, LLC with notifications on news.